Signaling pathways in cancer

Principles of Molecular Oncology: Third Edition

Volumn , Issue , 2008, Pages 153-188

  Kalderon, Daniel ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79956101732     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-59745-470-4_8     Document Type: Chapter

References (243)

1. Balazsi G, Oltvai ZN. Sensing your surroundings: How transcription- regulatory networks of the cell discern environmental signals. Sci STKE 2005;2005:pe20.
2. Schneper L, Duvel K, Broach JR. Sense and sensibility: Nutritional response and signal integration in yeast. Curr Opin Microbiol 2004;7:624-630.
3. Schwartz MA, Madhani HD. Principles of MAP kinase signaling specificity in Saccharomyces cerevisiae. Annu Rev Genet 2004;38:725-748.
4. Field GD, Sampath AP, Rieke F. Retinal processing near absolute threshold: From behavior to mechanism. Annu Rev Physiol 2005;67:491-514.
5. Komiyama T, Luo L. Development of wiring specificity in the olfactory system. Curr Opin Neurobiol 2006;16:67-73.
6. Miesenbock G, Kevrekidis IG. Optical imaging and control of genetically designated neurons in functioning circuits. Annu Rev Neurosci 2005;28:533-563.
7. Ronnett GV, Moon C. G proteins and olfactory signal transduction. Annu Rev Physiol 2002;64:189-222.
8. Crozatier M, Glise B, Vincent A. Connecting Hh, Dpp and EGF signalling in patterning of the Drosophila wing; the pivotal role of collier/knot in the AP organiser. Development 2002;129:4261-4269.
9. Grammont M, Irvine KD. Organizer activity of the polar cells during Drosophila oogenesis. Development 2002;129:5131-5140.
10. Irvine KD, Rauskolb C. Boundaries in development: Formation and function. Annu Rev Cell Dev Biol 2001;17:189-214.
11. Nagaraj R, Banerjee U. The little R cell that could. Int J Dev Biol 2004;48:755-760.
12. Shilo BZ. Regulating the dynamics of EGF receptor signaling in space and time. Development 2005;132:4017-4027.
13. Skeath JB, Thor S. Genetic control of Drosophila nerve cord development. Curr Opin Neurobiol 2003;13:8-15.
14. Bray SJ. Notch signalling: A simple pathway becomes complex. Nat Rev Mol Cell Biol 2006;7:678-689.
15. Freeman M. Feedback control of intercellular signalling in development. Nature 2000;408:313-319.
16. Miyazawa K, Shinozaki M, Hara T, Furuya T, Miyazono K. Two major Smad pathways in TGF-beta superfamily signalling. Genes Cells 2002;7(12):1191-204.
17. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006;127:469-480.
18. Veeman MT, Axelrod JD, Moon RT. A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling. Dev Cell 2003;5:367-377.
19. Wang HY, Malbon CC. Wnt signaling, Ca2+, and cyclic GMP: Visualizing Frizzled functions. Science 2003;300:1529-1530.
20. Dominguez M, Casares F. Organ specification-growth control connection: New in-sights from the Drosophila eye-antennal disc. Dev Dyn 2005;232:673-684.
21. Mahadeo DC, Parent CA. Signal relay during the life cycle of Dictyostelium. Curr Top Dev Biol 2006;73:115-140.
22. McGlinn E, Tabin CJ. Mechanistic insight into how Shh patterns the vertebrate limb. Curr Opin Genet Dev 2006;16:426-432.
23. Silver SJ, Rebay I. Signaling circuitries in development: Insights from the retinal determination gene network. Development 2005;132:3-13.
24. Tabata T, Takei Y. Morphogens, their identification and regulation. Development 2004;131:703-712.
25. Eldar A, Shilo BZ, Barkai N. Elucidating mechanisms underlying robustness of morphogen gradients. Curr Opin Genet Dev 2004;14:435-439.
26. Baylies MK, Michelson AM. Invertebrate myogenesis: Looking back to the future of muscle development. Curr Opin Genet Dev 2001;11:431-439.
27. Glise B, Jones DL, Ingham PW. Notch and Wingless modulate the response of cells to Hedgehog signalling in the Drosophila wing. Dev Biol 2002;248:93-106.
28. Nishita M, Hashimoto MK, Ogata S, et al. Interaction between Wnt and TGF-beta signalling pathways during formation of Spemann's organizer. Nature 2000;403:781-785.
29. Chen CK. The vertebrate phototransduction cascade: Amplification and termination mechanisms. Rev Physiol Biochem Pharmacol 2005;154:101-121.
30. Luttrell LM, Lefkowitz RJ. The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. J Cell Sci 2002;115:455-465.
31. Li Y, Baker NE. The roles of cis-inactivation by Notch ligands and of neuralized during eye and bristle patterning in Drosophila. BMC Dev Biol 2004;4:5.
32. Freeman M. Eye development: Stable cell fate decisions in insect colour vision. Curr Biol 2005;15:R924-926.
33. Hornstein E, Shomron N. Canalization of development by microRNAs. Nat Genet 2006;38 Suppl:S20-S24.
34. Bracken AP, Dietrich N, Pasini D, Hansen KH, Helin K. Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev 2006;20:1123-1136.
35. Lehner B, Crombie C, Tischler J, Fortunato A, Fraser AG. Systematic mapping of genetic interactions in Caenorhabditis elegans identifies common modifiers of diverse signaling pathways. Nat Genet 2006;38:896-903.
36. Rosenfeld MG, Lunyak VV, Glass CK. Sensors and signals: A coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev 2006;20:1405-1428.
37. Arvanitis C, Felsher DW. Conditional transgenic models define how MYC initiates and maintains tumorigenesis. Semin Cancer Biol 2006;16:313-317.
38. Christophorou MA, Ringshausen I, Finch AJ, Swigart LB, Evan GI. The pathological response to DNA damage does not contribute to p53-mediated tumour suppression. Nature 2006;443:214-217.
39. Mao J, Ligon KL, Rakhlin EY, et al. A novel somatic mouse model to survey tumorigenic potential applied to the Hedgehog pathway. Cancer Res 2006;66:10171-10178.
40. Marusyk A, Degregori J. Building a better model of cancer. Cell Div 2006;1:24.
41. Dalerba P, Cho RW, Clarke MF. Cancer Stem Cells: Models and Concepts. Annu Rev Med 2007;58:267-284.
42. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001;414:105-111.
43. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003;100:3983-3988.
44. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997;3:730-737.
45. Jordan CT. Searching for leukemia stem cells-not yet the end of the road? Cancer Cell 2006;10:253-254.
46. Brawley C, Matunis E. Regeneration of male germline stem cells by spermatogonial dedifferentiation in vivo. Science 2004;304:1331-1334.
47. Kai T, Spradling A. Differentiating germ cells can revert into functional stem cells in Drosophila melanogaster ovaries. Nature 2004;428:564-569.
48. Krivtsov AV, Twomey D, Feng Z, et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLLAF9. Nature 2006;442:818-822.
49. Loeb LA, Loeb KR, Anderson JP. Multiple mutations and cancer. Proc Natl Acad Sci USA 2003;100:776-781.
50. Nowell PC. Tumor progression: A brief historical perspective. Semin Cancer Biol 2002;12:261-266.
51. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med 2004;10:789-799.
52. Rangarajan A, Weinberg RA. Opinion: Comparative biology of mouse versus human cells: Modelling human cancer in mice. Nat Rev Cancer 2003;3:952-959.
53. Wang TL, Rago C, Silliman N, et al. Prevalence of somatic alterations in the colorectal cancer cell genome. Proc Natl Acad Sci U S A 2002;99:3076-3080.
54. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998;396:643-649.
55. Bodmer WF. Cancer genetics: Colorectal cancer as a model. J Hum Genet 2006;51:391-396.
56. Donahue SL, Lin Q, Cao S, Ruley HE. Carcinogens induce genome-wide loss of heterozygosity in normal stem cells without persistent chromosomal instability. Proc Natl Acad Sci USA 2006;103:11642-11646.
57. Duesberg P, Li R, Fabarius A, Hehlmann R. The chromosomal basis of cancer. Cell Oncol 2005;27:293-318.
58. Marx J. Debate surges over the origins of genomic defects in cancer. Science 2002;297:544-546.
59. Maser RS, DePinho RA. Connecting chromosomes, crisis, and cancer. Science 2002;297:565-569.
60. Pihan G, Doxsey SJ. Mutations and aneuploidy: Co-conspirators in cancer? Cancer Cell 2003;4:89-94.
61. Classon M, Harlow E. The retinoblastoma tumour suppressor in development and cancer. Nat Rev Cancer 2002;2:910-917.
62. Ortega S, Malumbres M, Barbacid M. Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta 2002;1602:73-87.
63. Sherr CJ. The Pezcoller lecture: Cancer cell cycles revisited. Cancer Res 2000;60:3689-3695.
64. Weissman I. Stem cell research: paths to cancer therapies and regenerative medicine. Jama 2005;294:1359-1366.
65. Betschinger J, Mechtler K, Knoblich JA. Asymmetric segregation of the tumor suppressor brat regulates self-renewal in Drosophila neural stem cells. Cell 2006;124:1241-1253.
66. Caussinus E, Gonzalez C. Induction of tumor growth by altered stem-cell asymmetric division in Drosophila melanogaster. Nat Genet 2005;37:1125-1129.
67. Lee CY, Robinson KJ, Doe CQ. Lgl, Pins and aPKC regulate neuroblast self-renewal versus differentiation. Nature 2006;439:594-598.
68. Lee CY, Wilkinson BD, Siegrist SE, Wharton RP, Doe CQ. Brat is a Miranda cargo protein that promotes neuronal differentiation and inhibits neuroblast self-renewal. Dev Cell 2006;10:441-449.
69. Morrison SJ, Kimble J. Asymmetric and symmetric stem-cell divisions in development and cancer. Nature 2006;441:1068-1074.
70. Ahn S, Joyner AL. In vivo analysis of quiescent adult neural stem cells responding to Sonic hedgehog. Nature 2005;437:894-897.
71. Crosnier C, Stamataki D, Lewis J. Organizing cell renewal in the intestine: Stem cells, signals and combinatorial control. Nat Rev Genet 2006;7:349-359.
72. Stecca B, Ruiz i Altaba A. Brain as a paradigm of organ growth: Hedgehog-Gli signaling in neural stem cells and brain tumors. J Neurobiol 2005;64:476-490.
73. Zhang Y, Kalderon D. Hedgehog acts as a somatic stem cell factor in the Drosophila ovary. Nature 2001;410:599-604.
74. Xie T, Spradling AC. A niche maintaining germ line stem cells in the Drosophila ovary. Science 2000;290:328-330.
75. Calabrese P, Tavare S, Shibata D. Pretumor progression: Clonal evolution of human stem cell populations. Am J Pathol 2004;164:1337-1346.
76. Leedham SJ, Schier S, Thliveris AT, Halberg RB, Newton MA, Wright NA. From gene mutations to tumours-stem cells in gastrointestinal carcinogenesis. Cell Prolif 2005;38:387-405.
77. Thliveris AT, Halberg RB, Clipson L, et al. Polyclonality of familial murine adenomas: Analyses of mouse chimeras with low tumor multiplicity suggest short-range interactions. Proc Natl Acad Sci U S A 2005;102:6960-6965.
78. Ting AH, McGarvey KM, Baylin SB. The cancer epigenome-components and functional correlates. Genes Dev 2006;20:3215-3231.
79. Holm TM, Jackson-Grusby L, Brambrink T, Yamada Y, Rideout WM, 3rd, Jaenisch R. Global loss of imprinting leads to widespread tumorigenesis in adult mice. Cancer Cell 2005;8:275-285.
80. Ringrose L, Paro R. Epigenetic regulation of cellular memory by the Polycomb and Trithorax group proteins. Annu Rev Genet 2004;38:413-443.
81. Baylin SB, Ohm JE. Epigenetic gene silencing in cancer-a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 2006;6:107-116.
82. Hwang HC, Clurman BE. Cyclin E in normal and neoplastic cell cycles. Oncogene 2005;24:2776-2786.
83. Malumbres M, Barbacid M. Mammalian cyclin-dependent kinases. Trends Biochem Sci 2005;30:630-641.
84. Sherr CJ, Roberts JM. Living with or without cyclins and cyclindependent kinases. Genes Dev 2004;18:2699-2711.
85. Dimova DK, Dyson NJ. The E2F transcriptional network: Old acquaintances with new faces. Oncogene 2005;24:2810-2826.
86. Knudsen ES, Knudsen KE. Retinoblastoma tumor suppressor: Where cancer meets the cell cycle. Exp Biol Med (Maywood) 2006;231:1271-1281.
87. Hinds PW. A confederacy of kinases: Cdk2 and Cdk4 conspire to control embryonic cell proliferation. Mol Cell 2006;22:432-433
88. Murray AW. Recycling the cell cycle: Cyclins revisited. Cell 2004;116:221-234.
89. Welcker M, Clurman B. Cell cycle: How cyclin E got its groove back. Curr Biol 2005;15:R810-812.
90. DeGregori J, Johnson DG. Distinct and overlapping roles for E2F family members in transcription, proliferation and apoptosis. Curr Mol Med 2006;6:739-748.
91. Guardavaccaro D, Pagano M. Stabilizers and destabilizers controlling cell cycle oscillators. Mol Cell 2006;22:1-4.
92. Johnson DG, Degregori J. Putting the oncogenic and tumor suppressive activities of E2F into context. Curr Mol Med 2006;6:731-738.
93. Gil J, Peters G. Regulation of the INK4b-ARF-INK4a tumour suppressor locus: All for one or one for all. Nat Rev Mol Cell Biol 2006;7:667-677.
94. Sherr CJ. Divorcing ARF and p53: An unsettled case. Nat Rev Cancer 2006;6:663-673.
95. Lowe SW, Cepero E, Evan G. Intrinsic tumour suppression. Nature 2004;432:307-315.
96. Reis T, Edgar BA. Negative regulation of dE2F1 by cyclin-dependent kinases controls cell cycle timing. Cell 2004;117:253-264.
97. Hariharan IK, Bilder D. Regulation of imaginal disc growth by tumor-suppressor genes in Drosophila. Annu Rev Genet 2006;40:335-361.
98. Inoki K, Ouyang H, Zhu T, et al. TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell 2006;126:955-968.
99. Frei C, Edgar BA. Drosophila cyclin D/Cdk4 requires Hif-1 prolyl hydroxylase to drive cell growth. Dev Cell 2004;6:241-251.
100. de la Cova C, Johnston LA. Myc in model organisms: A view from the flyroom. Semin Cancer Biol 2006;16:303-312.
101. Grewal SS, Li L, Orian A, Eisenman RN, Edgar BA. Mycdependent regulation of ribosomal RNA synthesis during Drosophila development. Nat Cell Biol 2005;7:295-302.
102. Edgar BA. From cell structure to transcription: Hippo forges a new path. Cell 2006;124:267-273.
103. Hariharan IK. Growth regulation: A beginning for the hippo pathway. Curr Biol 2006;16:R1037-R1039.
104. Thompson BJ, Cohen SM. The Hippo pathway regulates the bantam microRNA to control cell proliferation and apoptosis in Drosophila. Cell 2006;126:767-774.
105. Cho E, Feng Y, Rauskolb C, Maitra S, Fehon R, Irvine KD. Delineation of a Fat tumor suppressor pathway. Nat Genet 2006;38:1142-1150.
106. Danial NN, Korsmeyer SJ. Cell death: Critical control points. Cell 2004;116:205-219.
107. Narita M, Lowe SW. Senescence comes of age. Nat Med 2005;11:920-922.
108. Narita M, Narita M, Krizhanovsky V, et al. A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation. Cell 2006;126:503-514.
109. Harris SL, Levine AJ. The p53 pathway: Positive and negative feedback loops. Oncogene 2005;24:2899-2908.
110. Johnston LA, Gallant P. Control of growth and organ size in Drosophila. Bioessays 2002;24:54-64.
111. Vidal M, Cagan RL. Drosophila models for cancer research. Curr Opin Genet Dev 2006;16:10-16.
112. de la Cova C, Abril M, Bellosta P, Gallant P, Johnston LA. Drosophila myc regulates organ size by inducing cell competition. Cell 2004;117:107-116.
113. Moreno E, Basler K. dMyc transforms cells into supercompetitors. Cell 2004;117:117-129.
114. Rogulja D, Irvine KD. Regulation of cell proliferation by a morphogen gradient. Cell 2005;123:449-461.
115. Perez-Garijo A, Martin FA, Struhl G, Morata G. Dpp signaling and the induction of neoplastic tumors by caspase-inhibited apoptotic cells in Drosophila. Proc Natl Acad Sci U S A 2005;102:17664-17669.
116. Ryoo HD, Gorenc T, Steller H. Apoptotic cells can induce compensatory cell proliferation through the JNK and the Wingless signaling pathways. Dev Cell 2004;7:491-501.
117. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L. VEGF receptor signalling-in control of vascular function. Nat Rev Mol Cell Biol 2006;7:359-371.
118. Pouyssegur J, Dayan F, Mazure NM. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 2006;441:437-443.
119. Christofori G. New signals from the invasive front. Nature 2006;441:444-450.
120. Kang Y, Massague J. Epithelial-mesenchymal transitions: Twist in development and metastasis. Cell 2004;118:277-279.
121. Li X, Deng W, Nail CD, et al. Snail induction is an early response to Gli1 that determines the efficiency of epithelial transformation. Oncogene 2006;25:609-621.
122. Martin GS. Fly Src: The Yin and Yang of tumor invasion and tumor suppression. Cancer Cell 2006;9:4-6.
123. Qin Y, Capaldo C, Gumbiner BM, Macara IG. The mammalian Scribble polarity protein regulates epithelial cell adhesion and migration through E-cadherin. J Cell Biol 2005;171:1061-1071.
124. Mehlen P, Puisieux A. Metastasis: A question of life or death. Nat Rev Cancer 2006;6:449-458.
125. Arbouzova NI, Zeidler MP. JAK/STAT signalling in Drosophila: Insights into conserved regulatory and cellular functions. Development 2006;133:2605-2616.
126. Citri A, Yarden Y. EGF-ERBB signalling: Towards the systems level. Nat Rev Mol Cell Biol 2006;7:505-516.
127. Jorissen RN, Walker F, Pouliot N, Garrett TP, Ward CW, Burgess AW. Epidermal growth factor receptor: Mechanisms of activation and signalling. Exp Cell Res 2003;284:31-53.
128. Schlessinger J. Signal transduction. Autoinhibition control. Science 2003;300:750-752.
129. Schlessinger J. Common and distinct elements in cellular signaling via EGF and FGF receptors. Science 2004;306:1506-1507.
130. Oldham S, Hafen E. Insulin/IGF and target of rapamycin signaling: A TOR de force in growth control. Trends Cell Biol 2003;13:79-85.
131. Fambrough D, McClure K, Kazlauskas A, Lander ES. Diverse signaling pathways activated by growth factor receptors induce broadly overlapping, rather than independent, sets of genes. Cell 1999;97:727-741.
132. Hill CS, Treisman R. Growth factors and gene expression: Fresh insights from arrays. Sci STKE 1999;1999:PE1.
133. Murphy LO, Blenis J. MAPK signal specificity: The right place at the right time. Trends Biochem Sci 2006;31:268-275.
134. Rodriguez-Viciana P, Tetsu O, Oda K, Okada J, Rauen K, McCormick F. Cancer targets in the Ras pathway. Cold Spring Harb Symp Quant Biol 2005;70:461-467.
135. Schreck R, Rapp UR. Raf kinases: Oncogenesis and drug discovery. Int J Cancer 2006;119:2261-2271.
136. Weston CR, Lambright DG, Davis RJ. Signal transduction. MAP kinase signaling specificity. Science 2002;296:2345-2347.
137. Tootle TL, Rebay I. Post-translational modifications influence transcription factor activity: A view from the ETS superfamily. Bioessays 2005;27:285-298.
138. Roux PP, Richards SA, Blenis J. Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activity. Mol Cell Biol 2003;23:4796-4804.
139. Murphy LO, MacKeigan JP, Blenis J. A network of immediate early gene products propagates subtle differences in mitogenactivated protein kinase signal amplitude and duration. Mol Cell Biol 2004;24:144-153.
140. Sherr CJ, McCormick F. The RB and p53 pathways in cancer. Cancer Cell 2002;2:103-112.
141. Massague J. G1 cell-cycle control and cancer. Nature 2004;432:298-306.
142. Shaulian E, Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol 2002;4:E131-E136.
143. Anjum R, Roux PP, Ballif BA, Gygi SP, Blenis J. The tumor suppressor DAP kinase is a target of RSK-mediated survival signaling. Curr Biol 2005;15:1762-1767.
144. Shahbazian D, Roux PP, Mieulet V, et al. The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity. Embo J 2006;25:2781-2791.
145. Shaw RJ, Cantley LC. Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 2006;441:424-430.
146. Ruggero D, Sonenberg N. The Akt of translational control. Oncogene 2005;24:7426-7434.
147. Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell 2006;124:471-484.
148. Guertin DA, Sabatini DM. An expanding role for mTOR in cancer. Trends Mol Med 2005;11(8):353-361.
149. Hahn-Windgassen A, Nogueira V, Chen CC, Skeen JE, Sonenberg N, Hay N. Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity. J Biol Chem 2005;280:32081-32089.
150. Luo J, Manning BD, Cantley LC. Targeting the PI3K-Akt pathway in human cancer: Rationale and promise. Cancer Cell 2003;4:257-262.
151. Dorrello NV, Peschiaroli A, Guardavaccaro D, Colburn NH, Sherman NE, Pagano M. S6K1-and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth. Science 2006;314:467-471.
152. Neufeld TP. Body building: Regulation of shape and size by PI3K/ TOR signaling during development. Mech Dev 2003;120:1283-1296.
153. Hafen E, Stocker H. How are the sizes of cells, organs, and bodies controlled? PLoS Biol 2003;1:E86.
154. Prober DA, Edgar BA. Interactions between Ras1, dMyc, and dPI3K signaling in the developing Drosophila wing. Genes Dev 2002;16:2286-2299.
155. Rane SG, Reddy EP. JAKs, STATs and Src kinases in hematopoiesis. Oncogene 2002;21:3334-3358.
156. Schulze-Luehrmann J, Ghosh S. Antigen-receptor signaling to nuclear factor kappa B. Immunity 2006;25:701-715.
157. Turner SD, Alexander DR. Fusion tyrosine kinase mediated signalling pathways in the transformation of haematopoietic cells. Leukemia 2006;20:572-582.
158. Weil R, Israel A. Deciphering the pathway from the TCR to NFkappaB. Cell Death Differ 2006;13:826-833.
159. Giannone G, Sheetz MP. Substrate rigidity and force define form through tyrosine phosphatase and kinase pathways. Trends Cell Biol 2006;16:213-223.
160. Gilcrease MZ. Integrin signaling in epithelial cells. Cancer Lett 2007;247:1-25.
161. Gavi S, Shumay E, Wang HY, Malbon CC. G-protein-coupled receptors and tyrosine kinases: Crossroads in cell signaling and regulation. Trends Endocrinol Metab 2006;17:48-54.
162. Hupfeld CJ, Olefsky JM. Regulation of receptor tyrosine kinase signaling by GRKs and beta-arrestins. Annu Rev Physiol 2007; 69:561-577.
163. Ma L, Chen Z, Erdjument-Bromage H, Tempst P, Pandolfi PP. Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell 2005;121:179-193.
164. Rodriguez-Viciana P, Sabatier C, McCormick F. Signaling specificity by Ras family GTPases is determined by the full spectrum of effectors they regulate. Mol Cell Biol 2004;24:4943-4954.
165. Todaro GJ. Autocrine secretion of peptide growth factors by tumor cells. Natl Cancer Inst Monogr 1982;60:139-147.
166. Schulze A, Nicke B, Warne PH, Tomlinson S, Downward J. The transcriptional response to Raf activation is almost completely dependent on mitogen-activated protein kinase activity and shows a major autocrine component. Mol Biol Cell 2004;15:3450-3463.
167. Haber DA, Bell DW, Sordella R, et al. Molecular targeted therapy of lung cancer: EGFR mutations and response to EGFR inhibitors. Cold Spring Harb Symp Quant Biol 2005;70:419-426.
168. Politi K, Zakowski MF, Fan PD, Schonfeld EA, Pao W, Varmus HE. Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors. Genes Dev 2006;20:1496-1510.
169. Jabbour E, Cortes J, Kantarjian H. Novel tyrosine kinase inhibitors in chronic myelogenous leukemia. Curr Opin Oncol 2006;18:578-583.
170. Ji H, Sharpless NE, Wong KK. EGFR targeted therapy: View from biological standpoint. Cell Cycle 2006;5:2072-2076.
171. Samuels Y, Diaz LA, Jr., Schmidt-Kittler O, et al. Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell 2005;7:561-573.
172. Bergmann A, Tugentman M, Shilo BZ, Steller H. Regulation of cell number by MAPK-dependent control of apoptosis: A mechanism for trophic survival signaling. Dev Cell 2002;2:159-170.
173. Yu Q, Geng Y, Sicinski P. Specific protection against breast cancers by cyclin D1 ablation. Nature 2001;411:1017-1021.
174. Meyer N, Kim SS, Penn LZ. The Oscar-worthy role of Myc in apoptosis. Semin Cancer Biol 2006;16:275-287.
175. Pelengaris S, Khan M, Evan G. c-MYC: More than just a matter of life and death. Nat Rev Cancer 2002;2:764-776.
176. Hemann MT, Bric A, Teruya-Feldstein J, et al. Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants. Nature 2005;436:807-811.
177. He X, Semenov M, Tamai K, Zeng X. LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: Arrows point the way. Development 2004;131:1663-1677.
178. Kohn AD, Moon RT. Wnt and calcium signaling: Beta-cateninindependent pathways. Cell Calcium 2005;38:439-446.
179. Ma L, Wang HY. Suppression of cyclic GMP-dependent protein kinase is essential to the Wnt/cGMP/Ca2+ pathway. J Biol Chem 2006;281:30990-31001.
180. Peifer M, McEwen DG. The ballet of morphogenesis: Unveiling the hidden choreographers. Cell 2002;109:271-274.
181. Strutt D. Frizzled signalling and cell polarisation in Drosophila and vertebrates. Development 2003;130:4501-4513.
182. Walston T, Tuskey C, Edgar L, et al. Multiple Wnt signaling pathways converge to orient the mitotic spindle in early C. elegans embryos. Dev Cell 2004;7:831-841.
183. Ding Y, Dale T. Wnt signal transduction: Kinase cogs in a nano-machine? Trends Biochem Sci 2002;27:327-329.
184. Cliffe A, Hamada F, Bienz M. A role of Dishevelled in relocating Axin to the plasma membrane during wingless signaling. Curr Biol 2003;13:960-966.
185. Dale T. Kinase cogs go forward and reverse in the Wnt signaling machine. Nat Struct Mol Biol 2006;13:9-11.
186. Kalderon D. Similarities between the Hedgehog and Wnt signaling pathways. Trends Cell Biol 2002;12:523-531.
187. Katanaev VL, Ponzielli R, Semeriva M, Tomlinson A. Trimeric G protein-dependent frizzled signaling in Drosophila. Cell 2005;120:111-122.
188. Liu X, Rubin JS, Kimmel AR. Rapid, Wnt-induced changes in GSK3beta associations that regulate beta-catenin stabilization are mediated by Galpha proteins. Curr Biol 2005;15:1989-1997.
189. Tolwinski NS, Wieschaus E. Rethinking WNT signaling. Trends Genet 2004;20:177-181.
190. Stadeli R, Hoffmans R, Basler K. Transcription under the control of nuclear Arm/beta-catenin. Curr Biol 2006;16:R378-R385.
191. Sierra J, Yoshida T, Joazeiro CA, Jones KA. The APC tumor suppressor counteracts beta-catenin activation and H3K4 methylation at Wnt target genes. Genes Dev 2006;20:586-600.
192. Johnston LA, Sanders AL. Wingless promotes cell survival but constrains growth during Drosophila wing development. Nat Cell Biol 2003;5:827-833.
193. Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature 2005;434:843-850.
194. Nathke I. Cytoskeleton out of the cupboard: Colon cancer and cytoskeletal changes induced by loss of APC. Nat Rev Cancer 2006;6:967-974.
195. Bjerknes M, Cheng H. Gastrointestinal stem cells. II. Intestinal stem cells. Am J Physiol Gastrointest Liver Physiol 2005;289: G381-G387.
196. Owens DM, Watt FM. Contribution of stem cells and differentiated cells to epidermal tumours. Nat Rev Cancer 2003;3:444-451.
197. Blanpain C, Fuchs E. Epidermal stem cells of the skin. Annu Rev Cell Dev Biol 2006;22:339-373.
198. Lowry WE, Blanpain C, Nowak JA, Guasch G, Lewis L, Fuchs E. Defining the impact of beta-catenin/Tcf transactivation on epithelial stem cells. Genes Dev 2005;19:1596-1611.
199. Takeda H, Lyle S, Lazar AJ, Zouboulis CC, Smyth I, Watt FM. Human sebaceous tumors harbor inactivating mutations in LEF1. Nat Med 2006;12:395-397.
200. Reya T, Duncan AW, Ailles L, et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 2003;423:409-414.
201. Willert K, Brown JD, Danenberg E, et al. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 2003;423:448-452.
202. Trowbridge JJ, Moon RT, Bhatia M. Hematopoietic stem cell biology: Too much of a Wntthing. Nat Immunol 2006;7:1021-1023.
203. Fuccillo M, Rutlin M, Fishell G. Removal of Pax6 partially rescues the loss of ventral structures in Shh null mice. Cereb Cortex 2006;16:i96-i102.
204. Hooper JE, Scott MP. Communicating with Hedgehogs. Nat Rev Mol Cell Biol 2005;6:306-317.
205. Ingham PW, McMahon AP. Hedgehog signaling in animal development: Paradigms and principles. Genes Dev 2001; 15:3059-3087.
206. Ingham PW, Placzek M. Orchestrating ontogenesis: Variations on a theme by sonic hedgehog. Nat Rev Genet 2006;7:841-850.
207. Wilson CW, Chuang PT. New "hogs" in Hedgehog transport and signal reception. Cell 2006;125:435-438.
208. Ruiz-Gomez A, Molnar C, Holguin H, Mayor F, Jr., de Celis JF. The cell biology of Smo signalling and its relationships with GPCRs. Biochim Biophys Acta 2006;1768:901-912.
209. Tian L, Holmgren RA, Matouschek A. A conserved processing mechanism regulates the activity of transcription factors Cubitus interruptus and NF-kappaB. Nat Struct Mol Biol 2005;12:1045-1053.
210. Huangfu D, Anderson KV. Signaling from Smo to Ci/Gli: Conservation and divergence of Hedgehog pathways from Drosophila to vertebrates. Development 2006;133:3-14.
211. Duman-Scheel M, Weng L, Xin S, Du W. Hedgehog regulates cell growth and proliferation by inducing Cyclin D and Cyclin E. Nature 2002;417:299-304.
212. Hatton BA, Knoepfler PS, Kenney AM, et al. N-myc is an essential downstream effector of Shh signaling during both normal and neoplastic cerebellar growth. Cancer Res 2006;66:8655-8661.
213. Pasca di Magliano M, Hebrok M. Hedgehog signalling in cancer formation and maintenance. Nat Rev Cancer 2003;3:903-911.
214. Daya-Grosjean L, Couve-Privat S. Sonic hedgehog signaling in basal cell carcinomas. Cancer Lett 2005;225:181-192.
215. Hutchin ME, Kariapper MS, Grachtchouk M, et al. Sustained Hedgehog signaling is required for basal cell carcinoma proliferation and survival: Conditional skin tumorigenesis recapitulates the hair growth cycle. Genes Dev 2005;19:214-223.
216. Oliver TG, Read TA, Kessler JD, et al. Loss of patched and disruption of granule cell development in a pre-neoplastic stage of medulloblastoma. Development 2005;132:2425-2439.
217. Palma V, Lim DA, Dahmane N, et al. Sonic hedgehog controls stem cell behavior in the postnatal and adult brain. Development 2005;132:335-344.
218. Trowbridge JJ, Scott MP, Bhatia M. Hedgehog modulates cell cycle regulators in stem cells to control hematopoietic regeneration. Proc Natl Acad Sci USA 2006;103:14134-14139.
219. Beachy PA, Karhadkar SS, Berman DM. Tissue repair and stem cell renewal in carcinogenesis. Nature 2004;432:324-331.
220. Rubin LL, de Sauvage FJ. Targeting the Hedgehog pathway in cancer. Nat Rev Drug Discov 2006;5:1026-1033.
221. Watt FM. Unexpected Hedgehog-Wnt interactions in epithelial differentiation. Trends Mol Med 2004;10:577-580.
222. Lai EC. Notch signaling: Control of cell communication and cell fate. Development 2004;131:965-973.
223. Schweisguth F. Notch signaling activity. Curr Biol 2004;14: R129-138.
224. Fryer CJ, White JB, Jones KA. Mastermind recruits CycC: CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover. Mol Cell 2004;16:509-520.
225. Roy M, Pear WS, Aster JC. The multifaceted role of Notch in cancer. Curr Opin Genet Dev 2007;17:52-59.
226. Androutsellis-Theotokis A, Leker RR, Soldner F, et al. Notch signalling regulates stem cell numbers in vitro and in vivo. Nature 2006;442:823-826.
227. Attisano L, Wrana JL. Signal transduction by the TGF-beta superfamily. Science 2002;296:1646-1647.
228. Massague J, Gomis RR. The logic of TGFbeta signaling. FEBS Lett 2006;580:2811-2820.
229. Little SC, Mullins MC. Extracellular modulation of BMP activity in patterning the dorsoventral axis. Birth Defects Res C Embryo Today 2006;78:224-242.
230. He W, Dorn DC, Erdjument-Bromage H, Tempst P, Moore MA, Massague J. Hematopoiesis controlled by distinct TIF-1gamma and Smad4 branches of the TGFbeta pathway. Cell 2006;125:929-941.
231. Tam PP, Loebel DA, Tanaka SS. Building the mouse gastrula: Signals, asymmetry and lineages. Curr Opin Genet Dev 2006;16:419-425.
232. Liu A, Niswander LA. Bone morphogenetic protein signalling and vertebrate nervous system development. Nat Rev Neurosci 2005;6:945-954.
233. Zuzarte-Luis V, Hurle JM. Programmed cell death in the embryonic vertebrate limb. Semin Cell Dev Biol 2005;16:261-269.
234. Varga AC, Wrana JL. The disparate role of BMP in stem cell biology. Oncogene 2005;24:5713-5721.
235. Siegel PM, Massague J. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer 2003;3:807-821.
236. Wong MD, Jin Z, Xie T. Molecular mechanisms of germline stem cell regulation. Annu Rev Genet 2005;39:173-195.
237. Zhang J, Li L. BMP signaling and stem cell regulation. Dev Biol 2005;284:1-11.
238. Mitchell TJ, John S. Signal transducer and activator of transcription (STAT) signalling and T-cell lymphomas. Immunology 2005;114:301-312.
239. Rawlings JS, Rosler KM, Harrison DA. The JAK/STAT signaling pathway. J Cell Sci 2004;117:1281-1283.
240. Sampson M, Zhu QS, Corey SJ. Src kinases in G-CSF receptor signaling. Front Biosci 2007;12:1463-1474.
241. Khwaja A. The role of Janus kinases in haemopoiesis and haematological malignancy. Br J Haematol 2006;134:366-384.
242. Rizo A, Vellenga E, de Haan G, Schuringa JJ. Signaling pathways in self-renewing hematopoietic and leukemic stem cells: Do all stem cells need a niche? Hum Mol Genet 2006;15 Spec No 2:R210-219.
243. Valentino L, Pierre J. JAK/STAT signal transduction: Regulators and implication in hematological malignancies. Biochem Pharmacol 2006;71:713-721.